Sage Journals: Discover world-class research

Open access

Case report

First published 2022-3

Bullous Drug Reaction with Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

K. Geetha, Puja

Journal of Pharmacology and Pharmacotherapeutics

Open access

Review article

First published 2021

Pleiotropic Benefits of DPP-4 Inhibitors Beyond Glycemic Control

Seon Mee Kang, Jeong Hyun Park

Clinical Medicine Insights: Endocrinology and Diabetes

Retricted access

Research article

First published 2014-6

Management of a Prediabetes Case With the DPP-4 Inhibitor Sitagliptin

Jeremy L. Johnson, Katherine S. O’Neal, Christopher C. Pack [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2013-7

The tolerability and safety of DPP-4 inhibitors for the treatment of older people with type 2 diabetes mellitus: an observational study

Adie Viljoen, Claire L Meek, Roger Gadsby [...]

The British Journal of Diabetes & Vascular Disease

Open access

Research article

First published 2011

Saxagliptin: A Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Jay Shubrook, Randall Colucci, Aili Guo [...]

Clinical Medicine Insights: Endocrinology and Diabetes

Open access

Research article

First published 2024

Prevalence and Predictors of Adverse Events Associated With Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetic Patients: A Cross-sectional Study

Swetha R Reghunath, Ashna Chackochan, Girish Thunga [...]

Clinical Medicine Insights: Endocrinology and Diabetes

Free access

Research article

First published 2012-4

Cardiovascular effects of the DPP-4 inhibitors

Tessey Jose, Silvio E Inzucchi

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2007-1

The Physiology of Incretin Hormones and the Basis for DPP-4 Inhibitors

Skye Aiko McKennon, R. Keith Campbell

The Science of Diabetes Self-Management and Care

Open access

Review article

First published 2011

Sitagliptin: A DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Kathryn MS Johnson, Kathleen Schurr

Clinical Medicine Insights: Therapeutics

Open access

Review article

First published 2014-9

The effects of GLP-1 analogues,DPP-4 inhibitors and SGLT2 inhibitors on the renal system

Guntram Schernthaner, Carl Erik Mogensen, Gerit-Holger Schernthaner

Diabetes & Vascular Disease Research

Search results